Johnson & Johnson Services Inc Executive and Leadership Team

Joaquin Duato, the Chief Executive Officer at Johnson & Johnson Services Inc, directs the overarching corporate strategy for this global healthcare leader. Overseeing the integration of pharmaceutical research and medical technology development, the Chief Executive Officer ensures alignment between scientific innovation and patient care requirements. Joaquin Duato manages the executive board to drive long-term growth across oncology, immunology, and neuroscience sectors. By prioritizing high-impact medical solutions, the Chief Executive Officer maintains the company's competitive edge in international markets. This leadership position involves constant evaluation of market trends to optimize the portfolio of surgical products and medical devices. Through rigorous oversight of global operations, Duato secures the financial and operational health of the organization. The Chief Executive Officer fosters a culture of excellence, ensuring that every business unit contributes to the mission of improving human health worldwide while delivering consistent value to stakeholders and healthcare providers.

Eugene Woods, the Chief Executive Officer, Advocate Health at Johnson & Johnson Services Inc, manages strategic partnerships that bridge clinical service delivery with advanced medical technology. Overseeing the implementation of surgical products and medical devices within large-scale healthcare systems, the Chief Executive Officer, Advocate Health ensures that clinical outcomes remain the primary focus of all operational initiatives. Eugene Woods coordinates with internal research teams to refine the application of immunology and neuroscience solutions in real-world settings. By driving efficiency in patient care pathways, the Chief Executive Officer, Advocate Health optimizes the adoption of new medical technologies across diverse clinical environments. This role requires deep engagement with healthcare providers to identify unmet needs and translate those insights into actionable product improvements. Through strategic collaboration, Woods strengthens the market presence of the company, ensuring that advanced medical tools reach patients effectively while maintaining high standards of safety and efficacy in every clinical interaction.

Stephen Tremel, the Business Operations Chief Financial Officer & Vice President at Johnson & Johnson Services Inc, manages the financial health of the company's core business operations. Overseeing budget allocation and financial planning, the Business Operations Chief Financial Officer & Vice President ensures that resources are directed toward the most promising pharmaceutical and medical technology projects. Stephen Tremel drives operational efficiency by analyzing cost structures and identifying opportunities for financial optimization across all departments. By providing the executive team with accurate financial insights, the Business Operations Chief Financial Officer & Vice President supports informed decision-making regarding investments in oncology and immunology research. This leadership role involves maintaining strict financial controls to ensure the long-term sustainability of the organization. Through rigorous financial management, Tremel secures the capital necessary for the company to continue its mission of delivering innovative healthcare solutions, ensuring that the business remains profitable while fulfilling its commitment to patients and healthcare providers worldwide.

Joseph Wolk, the Chief Financial Officer & Executive VP at Johnson & Johnson Services Inc, directs the global financial strategy and capital allocation for the entire organization. Overseeing the company's financial reporting, investor relations, and treasury functions, the Chief Financial Officer & Executive VP ensures that the company maintains a strong balance sheet to support its extensive research and development efforts. Joseph Wolk manages the financial risks associated with the global pharmaceutical and medical technology markets. By driving fiscal discipline, the Chief Financial Officer & Executive VP enables the company to invest in breakthrough treatments for oncology and neuroscience. This leadership role involves close collaboration with the Board to communicate the company's financial performance and strategic direction to shareholders. Through strategic financial planning, Wolk secures the resources needed to sustain the company's growth and innovation, ensuring that the organization remains a dominant force in the global healthcare industry while delivering consistent value to all stakeholders.

John Chang, the Head of Company Strategy & Operation Office At Chief of Staff (China) & President, Office at Johnson & Johnson Services Inc, directs the strategic execution of business operations within the critical East Asian market. Overseeing the alignment of local initiatives with the global corporate mission, the Head of Company Strategy & Operation Office At Chief of Staff (China) & President, Office ensures that pharmaceutical and medical technology strategies are adapted to meet regional healthcare demands. John Chang manages the operational office to facilitate seamless communication between local teams and global leadership. By identifying growth opportunities in oncology and cardiovascular care, the Head of Company Strategy & Operation Office At Chief of Staff (China) & President, Office drives the expansion of the company's footprint in the region. This leadership role involves navigating complex regulatory environments to ensure the consistent delivery of high-quality medical products. Through strategic planning, Chang strengthens the company's competitive position and operational efficiency across the entire Chinese market.

Dominic Allocco, the Vice President and Associate Chief Marketing Officer at Johnson & Johnson Services Inc, architects the brand strategy for the company's extensive portfolio of pharmaceuticals and medical devices. Overseeing global marketing campaigns, the Vice President and Associate Chief Marketing Officer ensures that the value proposition of oncology and cardiovascular products reaches healthcare professionals with precision. Dominic Allocco manages cross-functional teams to align product messaging with the evolving needs of the global healthcare market. By analyzing consumer data and clinical feedback, the Vice President and Associate Chief Marketing Officer refines outreach strategies to maximize product adoption. This leadership role involves close collaboration with the sales and research departments to ensure that marketing efforts accurately reflect the scientific advancements of the company. Through strategic positioning, Allocco drives brand awareness and market penetration, ensuring that the organization remains a trusted partner for medical providers and patients seeking innovative healthcare solutions across all regions.

Diandra Hayban, the Global Director, Procurement & Chief Revenue Officer, Functional & Clinical Services at Johnson & Johnson Services Inc, manages the complex supply chain and revenue streams associated with clinical service offerings. Overseeing procurement strategies, the Global Director, Procurement & Chief Revenue Officer, Functional & Clinical Services ensures that the company maintains a reliable flow of materials for pharmaceutical and medical technology production. Diandra Hayban drives revenue growth by optimizing the delivery of functional services to healthcare providers worldwide. By streamlining operational costs and enhancing service efficiency, the Global Director, Procurement & Chief Revenue Officer, Functional & Clinical Services supports the company's mission to provide affordable and effective medical solutions. This role requires constant coordination with global logistics partners to ensure that surgical products and medical devices reach their destinations on time. Through rigorous financial oversight and strategic procurement, Hayban secures the operational stability necessary for the company to continue its work in immunology and neuroscience.

Antonio Darpino, the Vice President, Operation & Chief Information Officer at Johnson & Johnson Services Inc, architects the digital infrastructure that supports global manufacturing and operational processes. Overseeing the integration of advanced data analytics into the production of pharmaceuticals and medical devices, the Vice President, Operation & Chief Information Officer ensures that technology drives efficiency across all business units. Antonio Darpino manages the cybersecurity and information systems that protect the company's intellectual property and patient data. By implementing scalable digital solutions, the Vice President, Operation & Chief Information Officer optimizes the supply chain and manufacturing workflows for surgical products. This leadership role involves close collaboration with the executive team to align technological investments with long-term business goals. Through the modernization of internal systems, Darpino enhances the company's ability to respond to market demands, ensuring that the organization maintains its status as a leader in medical technology and pharmaceutical innovation.

Keith McKune, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) at Johnson & Johnson Services Inc, directs the rigorous scientific testing required for the release and stability of pharmaceutical products. Overseeing the analytical laboratories, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) ensures that every medicine and medical device meets the highest standards of quality and safety before reaching the market. Keith McKune manages the revenue impact of product quality by minimizing delays in the release process through advanced analytical techniques. By implementing precise testing protocols, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) supports the company's commitment to patient safety in oncology and immunology. This role involves constant interaction with regulatory bodies to ensure compliance with global standards. Through scientific leadership, McKune guarantees the integrity of the company's product pipeline, directly contributing to the reliability and success of the organization's medical offerings.

Jeff Srour, the Worldwide Vice President & Chief Information Officer, MedTech at Johnson & Johnson Services Inc, directs the digital transformation of the medical technology division. Overseeing the development of software-enabled medical devices and surgical platforms, the Worldwide Vice President & Chief Information Officer, MedTech ensures that technology enhances the precision and efficacy of surgical procedures. Jeff Srour manages the global IT strategy to support the rapid innovation cycles required in the MedTech sector. By integrating cloud-based solutions and data analytics, the Worldwide Vice President & Chief Information Officer, MedTech optimizes the performance of medical devices used in cardiovascular and neuroscience care. This leadership role involves collaborating with engineering teams to ensure that digital tools are seamlessly integrated into clinical workflows. Through strategic technological investment, Srour drives the modernization of the company's medical technology portfolio, ensuring that healthcare providers have access to the most advanced digital tools for patient treatment.